WCN26-8809 SUCCESSFUL TREATMENT OF RECURRENT DENSE DEPOSIT DISEASE POST KIDNEY TRANSPLANT WITH IPTACOPAN FOLLOWING ECULIZUMAB THERAPY

Read full text Summarise with VIRAT
Authors: Tanvi Deshpande, Jessie Wang, Sayna Norouzi, Craig William Zuppan
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Dense deposit disease (DDD) is caused by the dysregulation of the alternative complement pathway. DDD exhibits histological findings of intense C3 deposition greater than other immunoreactants on immunofluorescence microscopy and electron-dense deposits of the glomerular basement membrane lamina densa forming a sausage-like appearance on electron microscopy. The progression to end-stage kidney disease (ESRD) is within several years for a large portion of the patient population. Not only so, the rate of recurrence in kidney transplant recipients are high, ranging 80 to 100% in various studies, with cases noting recurrence within days to weeks post transplantation.

Fields of Study & Subjects

Complement system in diseases Renal Transplantation Outcomes and Treatments Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106324–106324
Publication date
25 March 2026
Language
EN